Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap
The UK government has formally opened a state-of-the-art vaccine research facility based at the UK Health and Security Agency (UKHSA) to improve the country's preparedness
A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound.<
“We believe all drugs will be designed using AI by 2030.” At the AI4 Artificial Intelligence Conference in Las Vegas (ai4.io/usa), on 9th August, E
Editor's Picks
